One approach that has gained attention is GLP-1 microdosing during perimenopause and menopause
Similar effects may theoretically apply to other pillars of conservative care, such as dietary modification or behavioral therapy, where lasting adaptations could outlive pharmacological effects
V., Shen, H., Grabarek, Z
Neuroinflammation: These peripheral events can trigger central neuroinflammatory responses
Mounjaro may work better for you if: Your primary goals include significant weight loss alongside blood sugar control You have not achieved target A1C levels with other GLP-1 medications Your healthcare provider recommends trying dual-action therapy You can tolerate the potentially stronger initial side effects Trulicity may suit you better if: You prefer a medication with a longer established safety record Your weight loss goals are modest You have achieved good results with GLP-1 medications previously You want to start with a medication your insurance readily covers Practical Tips for Success with Either Medication Regardless of which medication you choose in the Mounjaro vs Trulicity comparison, certain strategies help maximize your results and minimize discomfort

The regulatory picture is unusual and worth stating plainly: the afamelanotide molecule is FDA-approved but only as SCENESSE, a 16 mg controlled-release bioresorbable implant placed by a trained clinician to reduce phototoxic pain in adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder [1]